MAPK14 (T180/Y182) Antibody Blocking peptide
MAPK14 (T180/Y182) Antibody Blocking peptide
Product Specifications
Product Name Alternative
Mitogen-activated protein kinase 14, MAP kinase 14, MAPK 14, Cytokine suppressive anti-inflammatory drug-binding protein, CSAID-binding protein, CSBP, MAP kinase MXI2, MAX-interacting protein 2, Mitogen-activated protein kinase p38 alpha, MAP kinase p38 alpha, Stress-activated protein kinase 2a, SAPK2a, MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A
UniProt
Q16539
Field of Research
Cell Biology
Form
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Notes
For research use only.
Applications Notes
Synthetic peptide
AA Sequence
The synthetic peptide sequence used to generate the antibody orb1929460 was selected from the T180/Y182 region of human MAPK14. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC742940-500 1x 500 µL
CD79b (B-Cell Marker) (IGB/2940R), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC402947-500 1x 500 µL
IL3RA / CD123 (Acute Myeloid Leukemia Marker) (IL3RA/2947R), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
LY400719 100 µg
MCK10 (DDR1) (NM_001954) Human Over-expression Lysate
Sign In for Pricing
View Details 